Activin type II receptor — Drug Target

All drugs that target Activin type II receptor — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Activin receptor ligand trap

Phase 3 pipeline (1)

• ACE-536 · Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA · Activin receptor ligand trap · Hematology
  ACE-536 is an activin receptor ligand trap that inhibits activin signaling to promote erythropoiesis and increase hemoglobin levels.